Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat - Angiogenesis and angioma formation

被引:243
作者
Schwarz, ER
Speakman, MT
Patterson, M
Hale, SS
Isner, JM
Kedes, LH
Kloner, RA
机构
[1] Good Samaritan Hosp, Inst Heart, Los Angeles, CA 90017 USA
[2] Univ So Calif, Div Cardiol, Los Angeles, CA USA
[3] St Elisabeths Med Ctr, Div Cardiovasc Res, Boston, MA USA
[4] Tufts Univ, Sch Med, Boston, MA 02111 USA
[5] Univ So Calif, Dept Med, Los Angeles, CA USA
[6] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA USA
关键词
D O I
10.1016/S0735-1097(00)00522-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The effects of direct intramyocardial injection of the plasmid encoding vascular endothelial growth factor (phVEGF(165)) in the border zone of myocardial infarct tissue in rat hearts were investigated. BACKGROUND Controversy exists concerning the ability of VEGF to induce angiogenesis and enhance coronary flow in the myocardium. METHODS Sprague-Dawley rats received a ligation of the left coronary artery to induce myocardial infarction (MI). At 33.1 +/- 6.5 days, the rats were injected with phVEGF(165) at one location and control plasmid at a second location (500 mu g DNA, n = 24) or saline (n = 16). After 33.1 +/- 5.7 days, the hearts were excised for macroscopic and histologic analysis. Regional blood flow ratios were measured in 18 rats by radioactive microspheres. RESULTS phVEGF(165)-treated sites showed macroscopic angioma- like structures at the injection site while control DNA and saline injection sites did not. By histology, 21/24 phVEGF(165)-treated hearts showed increased focal epicardial blood vessel density and angioma-like formation. Quantitative morphometric evaluation in 20 phVEGF(165)-treated hearts revealed 44.4 +/- 10.5 vascular structures per field in phVEGF(165)-treated hearts versus 21.4 +/- 4.7 in control DNA injection sites (p < 0.05). Regional myocardial blood flow ratios between the injection site and noninfarcted area did not demonstrate any difference between phVEGF(165)-treated hearts (0.9 +/- 0.2) and saline-treated hearts (0.7 +/- 0.1). CONCLUSIONS Injection of DNA for VEGF in the border zone of MI in rat hearts induced angiogenesis. Angioma formation at the injection sites did not appear to contribute to regional myocardial blood how, which may be a limitation of gene therapy for this application. a Am Coil Cardiol 2000;35:1323-30) (C) 2000 by the American College of Cardiology.
引用
收藏
页码:1323 / 1330
页数:8
相关论文
共 50 条
  • [21] HORMONAL MODULATION OF A GENE INJECTED INTO RAT-HEART INVIVO
    KITSIS, RN
    BUTTRICK, PM
    MCNALLY, EM
    KAPLAN, ML
    LEINWAND, LA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (10) : 4138 - 4142
  • [22] KLONER RA, 1999, UNPUB INTRAMYOCARDIA
  • [23] Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury
    Lazarous, DF
    Shou, M
    Scheinowitz, M
    Hodge, E
    Thirumurti, V
    Kitsiou, AN
    Stiber, JA
    Lobo, AD
    Hunsberger, S
    Guetta, E
    Epstein, SE
    Unger, EF
    [J]. CIRCULATION, 1996, 94 (05) : 1074 - 1082
  • [24] Adenovirus-mediated gene transfer into infarcted myocardium: Feasibility, timing, and location of expression
    Leor, J
    Quinones, MJ
    Patterson, M
    Kedes, L
    Kloner, RA
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1996, 28 (10) : 2057 - 2067
  • [25] Leor J, 1996, CIRCULATION, V94, P332
  • [26] VASCULAR ENDOTHELIAL GROWTH-FACTOR IS A SECRETED ANGIOGENIC MITOGEN
    LEUNG, DW
    CACHIANES, G
    KUANG, WJ
    GOEDDEL, DV
    FERRARA, N
    [J]. SCIENCE, 1989, 246 (4935) : 1306 - 1309
  • [27] Angiogenesis by gene therapy: a new horizon for myocardial revascularization?
    Lewis, BS
    Flugelman, MY
    Weisz, A
    KerenTal, I
    Schaper, W
    [J]. CARDIOVASCULAR RESEARCH, 1997, 35 (03) : 490 - 497
  • [28] EXPRESSION OF RECOMBINANT GENES IN MYOCARDIUM INVIVO AFTER DIRECT INJECTION OF DNA
    LIN, H
    PARMACEK, MS
    MORLE, G
    BOLLING, S
    LEIDEN, JM
    [J]. CIRCULATION, 1990, 82 (06) : 2217 - 2221
  • [29] Hemodynamic effects of intracoronary VEGF delivery: evidence of tachyphylaxis and NO dependence of response
    Lopez, JJ
    Laham, RJ
    Carrozza, JP
    Tofukuji, M
    Sellke, FW
    Bunting, S
    Simons, M
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 273 (03): : H1317 - H1323
  • [30] Gene therapy for myocardial angiogenesis -: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia
    Losordo, DW
    Vale, PR
    Symes, JF
    Dunnington, CH
    Esakof, DD
    Maysky, M
    Ashare, AB
    Lathi, K
    Isner, JM
    [J]. CIRCULATION, 1998, 98 (25) : 2800 - 2804